12/3/2018

Granisetron Hydrochloride Injection

Reason for the Shortage

- Akorn did not provide a reason for the shortage.
- Fresenius Kabi did not provide a reason for the shortage.
- Hikma did not provide a reason for the shortage.

Available Products

- Granisetron Hydrochloride intravenous injection, Akorn, 1 mg/mL, 1 mL vial, 1 count, NDC 17478-0546-02
- Granisetron Hydrochloride intravenous injection, Akorn, 1 mg/mL, 4 mL multiple dose vial, 1 count, NDC 17478-0546-05
- Granisetron Hydrochloride intravenous injection, Fresenius Kabi, 0.1 mg/mL, 1 mL single dose vial, 10 count, NDC 63323-0317-01
- Granisetron Hydrochloride intravenous injection, Fresenius Kabi, 1 mg/mL, 1 mL single dose vial, 1 count, NDC 63323-0318-01
- Granisetron Hydrochloride intravenous injection, Fresenius Kabi, 1 mg/mL, 4 mL multiple dose vial, 1 count, NDC 63323-0319-04
- Granisetron Hydrochloride intravenous injection, Hikma, 1 mg/mL, 1 mL single dose vial, 10 count, NDC 00143-9744-10
- Granisetron Hydrochloride intravenous injection, Hikma, 1 mg/mL, 4 mL multiple dose vial, 10 count, NDC 00143-9745-05
- Granisetron Hydrochloride intravenous injection, Mylan, 1 mg/mL, 1 mL single dose vial, 1 count, NDC 67457-0863-01
- Granisetron Hydrochloride intravenous injection, Mylan, 1 mg/mL, 4 mL multiple dose vial, 1 count, NDC 67457-0864-04

Estimated Resupply Dates

- All marketed presentations are available.

Updated

Updated December 3, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 23, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.